Skip to main content
Clinical Trials/ISRCTN06959967
ISRCTN06959967
Completed
Not Applicable

Effect of progesterone administration on the duration of pregnancy after in vitro fertilisation (IVF)/ intra-cytoplasmic sperm injection (ICSI): a prospective randomised study

Marcyrl (Egypt)0 sites302 target enrollmentJuly 25, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prevention of preterm labour after IVF/ICSI
Sponsor
Marcyrl (Egypt)
Enrollment
302
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Marcyrl (Egypt)

Eligibility Criteria

Inclusion Criteria

  • Healthy women who became pregnant after IVF/ICSI (singleton or twin). Randomisation will be carried out, on average, during the 20th week of gestation.

Exclusion Criteria

  • 1\. Rupture of membranes
  • 2\. Smokers
  • 3\. Major known foetal anomalies
  • 4\. Uterine anomalies
  • 5\. Cervical cerclage
  • 6\. Treatment during this pregnancy with progesterone after 12 weeks' gestation (use up to 10 weeks' gestation is permitted)
  • 7\. Contraindications to tocolysis, including foetal distress, chorioamnionitis, preeclampsia, hemodynamic instability
  • 8\. Patients treated with oral beta adrenergics for asthma
  • 9\. Age \<18 years

Outcomes

Primary Outcomes

Not specified

Similar Trials